Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Puma Biotechnology ROA 2008-2019 | PBYI

Current and historical return on assets (ROA) values for Puma Biotechnology (PBYI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Puma Biotechnology ROA for the three months ending March 31, 2019 was -37.87%.
Puma Biotechnology ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-03-31 $-0.10B $0.33B -37.75%
2018-12-31 $-0.11B $0.26B -50.90%
2018-09-30 $-0.15B $0.23B -73.46%
2018-06-30 $-0.21B $0.23B -112.06%
2018-03-31 $-0.24B $0.17B -140.67%
2017-12-31 $-0.29B $0.17B -158.27%
2017-09-30 $-0.30B $0.18B -145.94%
2017-06-30 $-0.29B $0.17B -149.29%
2017-03-31 $-0.28B $0.22B -144.00%
2016-12-31 $-0.28B $0.25B -145.22%
2016-09-30 $-0.27B $0.13B -141.87%
2016-06-30 $-0.26B $0.17B -117.12%
2016-03-31 $-0.26B $0.21B -101.28%
2015-12-31 $-0.24B $0.24B -83.42%
2015-09-30 $-0.22B $0.27B -83.82%
2015-06-30 $-0.20B $0.30B -82.56%
2015-03-31 $-0.17B $0.33B -80.65%
2014-12-31 $-0.14B $0.16B -75.63%
2014-09-30 $-0.11B $0.17B -64.16%
2014-06-30 $-0.09B $0.20B -56.06%
2014-03-31 $-0.06B $0.22B -44.44%
2013-12-31 $-0.06B $0.10B -45.08%
2013-09-30 $-0.06B $0.12B -45.52%
2013-06-30 $-0.07B $0.13B -63.89%
2013-03-31 $-0.08B $0.14B -80.43%
2012-12-31 $-0.08B $0.15B -105.26%
2012-09-30 $-0.06B $0.04B -134.04%
2012-06-30 $-0.04B $0.04B -97.37%
2012-03-31 $-0.02B $0.05B -81.48%
2011-12-31 $-0.01B $0.06B -72.73%
2011-09-30 $0.00B $0.00B nan%
2011-06-30 $0.00B $0.00B nan%
2011-03-31 $0.00B $0.00B nan%
2010-12-31 $0.00B $0.00B nan%
2010-09-30 $0.00B $0.00B nan%
2010-06-30 $0.00B $0.00B nan%
2010-03-31 $0.00B $0.00B nan%
2009-12-31 $0.00B $0.00B nan%
2009-09-30 $0.00B $0.00B nan%
2009-06-30 $0.00B $0.00B nan%
2009-03-31 $0.00B $0.00B nan%
2008-12-31 $0.00B $0.00B nan%
2008-09-30 $0.00B $0.00B nan%
2008-06-30 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.495B $0.251B
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, in-licensing, development and commercialization of novel therapeutics for the treatment of cancer. Its products under development include PB272 (oral neratinib) for the treatment of patients with human epidermal growth factor receptor type 2 (HER2) positive metastatic breast cancer and gastric cancer and PB272 (neratinib intravenous) for the treatment of patients with advanced cancer. Puma Biotechnology, Inc. is headquartered in Los Angeles, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Celgene (CELG) United States $68.065B 11.53
Illumina (ILMN) United States $50.568B 58.60
Biogen (BIIB) United States $44.144B 8.38
Vertex Pharmaceuticals (VRTX) United States $43.597B 52.70
Regeneron Pharmaceuticals (REGN) United States $33.355B 15.68
Alexion Pharmaceuticals (ALXN) United States $26.444B 14.97
Incyte (INCY) United States $16.664B 67.57
BioMarin Pharmaceutical (BMRN) United States $14.476B 0.00
Exact Sciences (EXAS) United States $14.177B 0.00
Seattle Genetics (SGEN) United States $11.050B 0.00
QIAGEN (QGEN) Netherlands $8.912B 29.27
Sarepta Therapeutics (SRPT) United States $8.867B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.890B 53.83
Guardant Health (GH) United States $7.737B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.461B 0.00
Array BioPharma (ARRY) United States $6.562B 0.00
Bluebird Bio (BLUE) United States $6.486B 0.00
Galapagos (GLPG) Belgium $6.209B 0.00
Amarin (AMRN) Ireland $5.979B 0.00
Exelixis (EXEL) United States $5.945B 15.15
BeiGene (BGNE) Cayman Islands $5.486B 0.00
Ascendis Pharma (ASND) Denmark $5.094B 0.00
Moderna (MRNA) United States $5.067B 0.00
Blueprint Medicines (BPMC) United States $4.431B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.006B 0.00
Spark Therapeutics (ONCE) United States $3.753B 0.00
China Biologic Products (CBPO) China $3.650B 23.18
Repligen (RGEN) United States $3.505B 87.32
ACADIA Pharmaceuticals (ACAD) United States $3.497B 0.00
Alkermes (ALKS) Ireland $3.435B 0.00
Mirati Therapeutics (MRTX) United States $3.398B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.285B 0.00
Allogene Therapeutics (ALLO) United States $3.212B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.136B 0.00
Global Blood Therapeutics (GBT) United States $3.045B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.796B 0.00
UniQure (QURE) Netherlands $2.742B 0.00
Arena Pharmaceuticals (ARNA) United States $2.742B 5.57
Amicus Therapeutics (FOLD) United States $2.616B 0.00
Medicines (MDCO) United States $2.607B 0.00
Reata Pharmaceuticals (RETA) United States $2.452B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.369B 0.00
Immunomedics (IMMU) United States $2.367B 0.00
Lion Biotechnologies (IOVA) United States $2.359B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.289B 0.00
Halozyme Therapeutics (HALO) United States $2.289B 0.00
Emergent Biosolutions (EBS) United States $2.229B 19.36
NeoGenomics (NEO) United States $2.204B 144.31
MyoKardia (MYOK) United States $2.129B 0.00
Ligand Pharmaceuticals (LGND) United States $2.112B 17.49
Akcea Therapeutics (AKCA) United States $2.110B 0.00
Acceleron Pharma (XLRN) United States $1.983B 0.00
Genomic Health (GHDX) United States $1.896B 40.27
AnaptysBio (ANAB) United States $1.882B 0.00
Insmed (INSM) United States $1.848B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.829B 0.00
Allakos (ALLK) United States $1.812B 0.00
Denali Therapeutics (DNLI) United States $1.786B 0.00
REGENXBIO (RGNX) United States $1.768B 0.00
Myriad Genetics (MYGN) United States $1.762B 17.53
Audentes Therapeutics (BOLD) United States $1.681B 0.00
Cambrex (CBM) United States $1.443B 18.24
Innoviva (INVA) United States $1.429B 3.95
Alector (ALEC) United States $1.388B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.387B 0.00
Apellis Pharmaceuticals (APLS) United States $1.339B 0.00
Gossamer Bio (GOSS) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.293B 0.00
Aimmune Therapeutics (AIMT) United States $1.250B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.249B 0.00
Athenex (ATNX) United States $1.194B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.181B 0.00
Fate Therapeutics (FATE) United States $1.162B 0.00
Eidos Therapeutics (EIDX) United States $1.157B 0.00
Rubius Therapeutics (RUBY) United States $1.107B 0.00
Sangamo Therapeutics (SGMO) United States $1.074B 0.00
Editas Medicine (EDIT) United States $1.070B 0.00
Epizyme (EPZM) United States $1.056B 0.00
Atara Biotherapeutics (ATRA) United States $1.012B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.008B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.005B 0.00
Codexis (CDXS) United States $0.952B 0.00
NGM Biopharmaceuticals (NGM) United States $0.906B 0.00
RA PHARMCTL INC (RARX) United States $0.899B 0.00
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
ANI Pharmaceuticals (ANIP) United States $0.850B 15.07
ZIOPHARM Oncology Inc (ZIOP) United States $0.847B 0.00
CORTEXYME INC (CRTX) United States $0.843B 0.00
Principia Biopharma (PRNB) United States $0.827B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.819B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.811B 0.00
Retrophin (RTRX) United States $0.796B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.779B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.773B 36.50
Cara Therapeutics (CARA) United States $0.770B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.770B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.763B 0.00
Axsome Therapeutics (AXSM) United States $0.760B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.748B 0.00
Kura Oncology (KURA) United States $0.711B 0.00
Vericel (VCEL) United States $0.704B 0.00
G1 THERAPEUTICS (GTHX) United States $0.696B 0.00
Twist Bioscience (TWST) United States $0.694B 0.00
Intra-Cellular Therapies (ITCI) United States $0.690B 0.00
Clovis Oncology (CLVS) United States $0.686B 0.00
Adverum Biotechnologies (ADVM) United States $0.686B 0.00
MeiraGTx Holdings (MGTX) United States $0.684B 0.00
Arvinas (ARVN) United States $0.669B 0.00
Zymeworks (ZYME) Canada $0.657B 0.00
Zealand Pharma (ZEAL) Denmark $0.654B 7.64
Precision BioSciences (DTIL) United States $0.653B 0.00
Intellia Therapeutics (NTLA) United States $0.635B 0.00
Myovant Sciences (MYOV) United Kingdom $0.627B 0.00
Cellectis (CLLS) France $0.620B 0.00
Stemline Therapeutics (STML) United States $0.619B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.619B 0.00
Heska (HSKA) United States $0.616B 63.08
Lexicon Pharmaceuticals (LXRX) United States $0.600B 0.00
Viking Therapeutics (VKTX) United States $0.566B 0.00
Anika Therapeutics (ANIK) United States $0.565B 19.31
Cytokineticsorporated (CYTK) United States $0.551B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.490B 0.00
UROGEN PHARMA (URGN) United States $0.485B 0.00
DBV Technologies (DBVT) France $0.484B 0.00
Magenta Therapeutics (MGTA) United States $0.483B 0.00
Revance Therapeutics (RVNC) United States $0.478B 0.00
Mesoblast (MESO) Australia $0.477B 0.00
BeyondSpring (BYSI) United States $0.475B 0.00
CytomX Therapeutics (CTMX) United States $0.471B 0.00
ObsEva SA (OBSV) Switzerland $0.459B 0.00
Scholar Rock Holding (SRRK) United States $0.448B 0.00
Kodiak Sciences (KOD) United States $0.442B 0.00
Provention Bio (PRVB) United States $0.438B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.428B 0.00
Kaleido Biosciences (KLDO) $0.425B 0.00
Synthorx (THOR) United States $0.411B 0.00
MediciNova (MNOV) United States $0.402B 0.00
Replimune (REPL) United States $0.398B 0.00
AC Immune SA (ACIU) Switzerland $0.397B 25.57
Krystal Biotech (KRYS) United States $0.393B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.387B 0.00
Sorrento Therapeutics (SRNE) United States $0.386B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.382B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.377B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.375B 0.00
Prothena (PRTA) Ireland $0.375B 0.00
UNITY Biotechnology (UBX) $0.375B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Arcus Biosciences (RCUS) United States $0.369B 0.00
Acorda Therapeutics (ACOR) United States $0.362B 6.38
Agenus (AGEN) United States $0.357B 0.00
Senesco Technologies (ELOX) United States $0.352B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
PDL BioPharma (PDLI) United States $0.348B 8.31
NEXTCURE INC (NXTC) United States $0.341B 0.00
LogicBio Therapeutics (LOGC) United States $0.334B 0.00
AVROBIO (AVRO) United States $0.327B 0.00
ResTORbio (TORC) United States $0.320B 0.00
Merus (MRUS) Netherlands $0.305B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Kindred Biosciences (KIN) United States $0.302B 0.00
PHASEBIO PHARMA (PHAS) United States $0.285B 0.00
Geron (GERN) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.273B 0.00
Cyclerion Therapeutics (CYCN) United States $0.268B 0.00
Cellular Biomedicine (CBMG) United States $0.265B 0.00
XBiotech (XBIT) United States $0.258B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.254B 0.00
AXCELLA HEALTH (AXLA) United States $0.252B 0.00
Athersys (ATHX) United States $0.249B 0.00
Chiasma (CHMA) United States $0.248B 0.00
Dynavax Technologies (DVAX) United States $0.248B 0.00
Urovant Sciences (UROV) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.236B 0.00
Syros Pharmaceuticals (SYRS) United States $0.233B 0.00
Constellation Pharmaceuticals (CNST) United States $0.233B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.232B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.231B 0.00
Cerecor (CERC) United States $0.228B 0.00
Evelo Biosciences (EVLO) United States $0.225B 0.00
ChromaDex (CDXC) United States $0.225B 0.00
Neothetics (EVFM) United States $0.225B 0.00
Avid Bioservices (CDMO) United States $0.222B 0.00
Celcuity (CELC) United States $0.221B 0.00
Kamada (KMDA) Israel $0.221B 8.56
Kadmon Holdings (KDMN) United States $0.218B 0.00
ADMA Biologics Inc (ADMA) United States $0.217B 0.00
MannKind (MNKD) United States $0.216B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.213B 0.00
Five Prime Therapeutics (FPRX) United States $0.213B 0.00
IDEAYA BIOSCI (IDYA) United States $0.211B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.209B 0.00
Enochian BioSciences (ENOB) United States $0.205B 0.00
Affimed (AFMD) Germany $0.199B 0.00
Spero Therapeutics (SPRO) United States $0.198B 0.00
Synlogic (SYBX) United States $0.196B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.195B 0.00
Enzo Biochem (ENZ) United States $0.194B 0.00
HOOKIPA PHARMA (HOOK) United States $0.191B 0.00
Celyad SA (CYAD) Belgium $0.185B 0.00
VBI Vaccines (VBIV) United States $0.185B 0.00
Mersana Therapeutics (MRSN) United States $0.183B 0.00
Arsanis (XFOR) United States $0.181B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.178B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
Strongbridge Biopharma (SBBP) United States $0.174B 10.03
Compugen (CGEN) Israel $0.174B 0.00
Kala Pharmaceuticals (KALA) United States $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Kezar Life Sciences (KZR) United States $0.171B 0.00
OvaScience (MLND) United States $0.171B 0.00
Checkpoint Therapeutics (CKPT) United States $0.170B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.162B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Dyadic (DYAI) United States $0.158B 0.00
Intec Pharma (NTEC) Israel $0.155B 0.00
Anavex Life Sciences (AVXL) United States $0.154B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
XOMA (XOMA) United States $0.146B 0.00
APPLIED THERAPT (APLT) United States $0.146B 0.00
Aduro Biotech (ADRO) United States $0.143B 0.00
Mustang Bio (MBIO) United States $0.141B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
TREVI THERAPTCS (TRVI) United States $0.134B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
Aptose Biosciences (APTO) Canada $0.119B 0.00
Novavax (NVAX) United States $0.117B 0.00
Axovant Sciences (AXGT) United Kingdom $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.112B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.112B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
INmune Bio (INMB) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.104B 0.00
Equillium (EQ) United States $0.104B 0.00
Verastem (VSTM) United States $0.103B 0.00
NantKwest (NK) United States $0.101B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.099B 0.00
Aptinyx (APTX) United States $0.099B 0.00
Trevena (TRVN) United States $0.098B 0.00
Selecta Biosciences (SELB) United States $0.094B 0.00
Seres Therapeutics (MCRB) United States $0.094B 0.00
Allena Pharmaceuticals (ALNA) United States $0.089B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.077B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.075B 0.00
Cocrystal Pharma (COCP) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.074B 0.00
Unum Therapeutics (UMRX) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
Cohbar (CWBR) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
VTv Therapeutics (VTVT) United States $0.070B 0.00
OVID THERAPEUTC (OVID) United States $0.068B 0.00
Alcobra (ARCT) United States $0.068B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Hoth Therapeutics (HOTH) United States $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Ophthotech (ISEE) United States $0.054B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.051B 0.00
AEterna Zentaris (AEZS) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Bellerophon Therapeutics (BLPH) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
Cidara Therapeutics (CDTX) United States $0.041B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Evogene (EVGN) Israel $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.033B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Aytu Bioscience (AYTU) United States $0.029B 0.00
Histogenics (HSGX) United States $0.028B 0.00
Bison Capital Acquisition (XYN) China $0.027B 0.00
Sophiris Bio (SPHS) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
GTx (ONCT) United States $0.020B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Vical (VICL) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Advaxis (ADXS) United States $0.014B 0.00
Motif Bio Plc (MTFB) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
IMMURON LTD (IMRN) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.004B 0.00
Alliqua BioMedical (ADYX) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00